If COVID taught us anything, the government is going to let these drugs expire useless, incinerate them, refuse to replenish them, and import loads of fakes when an actual crisis hits.
Snark aside, this may not be the case this time around. Relevant snippet:
> 2004 Project Bioshield Act and $290 million in Project BioShield designated funding to purchase this supply of the drug. Amgen will maintain this supply in vendor-managed inventory. This approach decreases life-cycle management costs for taxpayers because doses that near expiration can be rotated into the commercial market for rapid use prior to expiry and new doses can be added to the government supply.
I'm guessing $290M covers both the cost of the drugs as well as storage for some number of years. Would be nice to know for how long.
Snark aside, this may not be the case this time around. Relevant snippet:
> 2004 Project Bioshield Act and $290 million in Project BioShield designated funding to purchase this supply of the drug. Amgen will maintain this supply in vendor-managed inventory. This approach decreases life-cycle management costs for taxpayers because doses that near expiration can be rotated into the commercial market for rapid use prior to expiry and new doses can be added to the government supply.
I'm guessing $290M covers both the cost of the drugs as well as storage for some number of years. Would be nice to know for how long.